dl-3-n-butylphthalide Regulate the Level of Autophagy and BACE1 in Neuro-2a/APP695 Cells Exposed to Oxygen-glucose-deprivation

Rong-fu CHEN,Ting ZHANG,Wen-qi CHEN,Fang SHEN,Kang-yong LIU,Zhao-hua GU,Xiao-jiang SUN
2015-01-01
Abstract:Aim To investigate the possible mechanism that dl-3-n-butylph thalide (NBP) regulate the expression of BACE1, key rate-limiting enzyme in Aβmetabolism, through oxygen-glucose-deprivation (OGD) in cells in vitro. Methods The cell model of cerebral ischemia in vitro was set up through OGD in neuro-2a/APP695 cells stably over-expressing wild-type human APP695 protein. Then autophagy regulation by NBP will be observed and analyzed by the mothod of MDC staining, immunoblotting, and transmission electron microscopy technology. Results The expression of BACE1 decreased in all groups with OGD treatments while increased in the group of 3-MA in neuro-2a/APP695 cells (P<0.01). And, the level of BACE1 declined in the group of NBP pretreatment (P<0.05). Moreover, the anti-apoptoasis protein of Bcl-2 up-regulated by NBP pretreatment against the stress damage in cells exposed to OGD. Conclusion The expression of BACE1 can be down-regulated by NBP medication of which the related mechanism may be through the inhibition of excessive autophagy and (or) anti-apoptotic pathway.
What problem does this paper attempt to address?